Immune responses and protection against H5N1 highly pathogenic avian influenza virus induced by the newcastle disease virus H5 vaccine in ducks

Avian Diseases

Volumn 56, Issue 4 SUPPL.1, 2012, Pages 940-948

  Ferreira, Helena Lage ^a   Pirlot, Jean François ^b   Reynard, Frédéric ^c   Van Den Berg, Thierry ^b   Bublot, Michel ^c   Lambrecht, Bénédicte ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b VETERINARY AND AGROCHEMICAL RESEARCH CENTRE   (Belgium)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

ducks; immune response; mule ducks; NDV H5; vaccination

Indexed keywords

HEMAGGLUTININ, AVIAN INFLUENZA A VIRUS; IMMUNOGLOBULIN; IMMUNOGLOBULIN Y; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE;

ANIMAL; AVIAN INFLUENZA; BLOOD; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOLOGY; DUCK; DUODENUM; FEMALE; IMMUNOLOGY; INFLUENZA VIRUS A H5N1; MALE; NEWCASTLE DISEASE PARAMYXOVIRUS; PHYSIOLOGY; SPLEEN; T LYMPHOCYTE; VIROLOGY;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; DUCKS; DUODENUM; FEMALE; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; IMMUNOGLOBULINS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; MALE; NEWCASTLE DISEASE VIRUS; SPLEEN; T-LYMPHOCYTES; VIRAL VACCINES;

ANAS; ANAS PLATYRHYNCHOS; AVES; AVIAN INFLUENZA VIRUS; CAIRINA MOSCHATA; NEWCASTLE DISEASE VIRUS;

EID: 84871953926     PISSN: 00052086     EISSN: None     Source Type: Journal    
DOI: 10.1637/10148-040812-ResNote.1     Document Type: Conference Paper

References (56)

1. Beato, M. S., A. Toffan, R. De Nardi, A. Cristalli, C. Terregino, G. Cattoli, and I. Capua. A conventional, inactivated oil emulsion vaccine suppresses shedding and prevents viral meat colonisation in commercial (Pekin) ducks challenged with HPAI H5N1. Vaccine 25:4064-4072. 2007. (Pubitemid 46621133)
2. Cherbonnel, M., J. Lamande, C. Allee, A. Schmitz, K. Ogor, G. Le Gall-Recule, M. O. Le Bras, C. Guillemoto, I. Pierre, J. P. Picault, and V. Jestin. Virologic findings in selected free-range mule duck farms at high risk for avian influenza infection. Avian Dis. 51:408-413. 2007. (Pubitemid 46671320)
3. De Vriese, J., M. Steensels, V. Palya, Y. Gardin, K. M. Dorsey, B. Lambrecht, S. Van Borm, and T. van den Berg. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies' interference with the protection elicited by avian influenza-inactivated vaccines in progeny. Avian Dis. 54:246-252. 2010.
4. Fereidouni, S. R., C. Grund, R. Hauslaigner, E. Lange, H. Wilking, T. C. Harder, M. Beer, and E. Starick. Dynamics of specific antibody responses induced in mallards after infection by or immunization with low pathogenicity avian influenza viruses. Avian Dis. 54:79-85. 2010.
5. Ferreira, H. L., J. F. Pirlot, B. Kaspers, S. Kothlow, T. van den Berg, and B. Lambrecht. Development of specific enzyme-linked immunosorbent assays to evaluate the duck immune response after experimental infection with H5N1 and H7N1 low-pathogenicity avian influenza viruses. Avian Dis. 54:660-667. 2010.
6. Fouchier, R. A., G. F. Rimmelzwaan, T. Kuiken, and A. D. Osterhaus. Newer respiratory virus infections: human metapneumovirus, avian influenza virus, and human coronaviruses. Curr. Opin. Infect. Dis. 18:141-146. 2005. (Pubitemid 40380213)
7. Ganapathy, K., V. Todd, P. Cargill, E. Montiel, and R. C. Jones. Interaction between a live avian pneumovirus vaccine and two different Newcastle disease virus vaccines in broiler chickens with maternal antibodies to Newcastle disease virus. Avian Pathol. 35:429-434. 2006. (Pubitemid 44851165)
8. Ge, J., G. Deng, Z. Wen, G. Tian, Y. Wang, J. Shi, X. Wang, Y. Li, S. Hu, Y. Jiang, C. Yang, K. Yu, Z. Bu, and H. Chen. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J. Virol. 81:150-158. 2007. (Pubitemid 44975155)
9. Gilbert, M., P. Chaitaweesub, T. Parakamawongsa, S. Premashthira, T. Tiensin, W. Kalpravidh, H. Wagner, and J. Slingenbergh. Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg. Infect. Dis. 12:227-234. 2006.
10. Hauslaigner, R., J. Sonnenburg, S. Kothlow, B. Kaspers, C. Staubach, and C. Grund. Evaluation of an indirect enzyme-linked immunosorbent assay to study the specific humoral immune response of Muscovy ducks (Cairina moschata) and domestic geese (Anser anser var. domestica) after vaccination against Newcastle disease virus. Avian Pathol. 38:89-95. 2009.
11. Henning, J., K. A. Henning, J. M. Morton, N. T. Long, N. T. Ha, L. T. Vu, P. P. Vu, D. M. Hoa, and J. Meers. Highly pathogenic avian influenza (H5N1) in ducks and in-contact chickens in backyard and smallholder commercial duck farms in Viet Nam. Prev. Vet. Med. 2010.
12. James, C. M., Y. Y. Foong, J. P. Mansfield, A. R. Vind, S. G. Fenwick, and T. M. Ellis. Evaluation of a positive marker of avian influenza vaccination in ducks for use in H5N1 surveillance. Vaccine 26:5345-5351. 2008.
13. Jeong, O. M., M. C. Kim, M. J. Kim, H. M. Kang, H. R. Kim, Y. J. Kim, S. J. Joh, J. H. Kwon, and Y. J. Lee. Experimental infection of chickens, ducks and quails with the highly pathogenic H5N1 avian influenza virus. J. Vet. Sci. 10:53-60. 2009.
14. Jeurissen, S. H., E. M. Janse, P. R. Lehrbach, E. E. Haddad, A. Avakian, and C. E. Whitfill. The working mechanism of an immune complex vaccine that protects chickens against infectious bursal disease. Immunology 95:494-500. 1998. (Pubitemid 28505709)
15. Jourdain, E., G. Gunnarsson, J. Wahlgren, N. Latorre-Margalef, C. Brojer, S. Sahlin, L. Svensson, J. Waldenstrom, A. Lundkvist, and B. Olsen. Influenza virus in a natural host, the mallard: experimental infection data. PLoS One 5:e8935. 2010.
16. Kida, H., R. Yanagawa, and Y. Matsuoka. Duck influenza lacking evidence of disease signs and immune response. Infect. Immun. 30:547-553. 1980. (Pubitemid 10030017)
17. Kim, J. K., P. Seiler, H. L. Forrest, A. M. Khalenkov, J. Franks, M. Kumar, W. B. Karesh, M. Gilbert, R. Sodnomdarjaa, B. Douangngeun, E. A. Govorkova, and R. G. Webster. Pathogenicity and vaccine efficacy of different clades of Asian H5N1 avian influenza A viruses in domestic ducks. J. Virol. 82:11374-11382. 2008.
18. Kishida, N., Y. Sakoda, N. Isoda, K. Matsuda, M. Eto, Y. Sunaga, T. Umemura, and H. Kida. Pathogenicity of H5 influenza viruses for ducks. Arch. Virol. 150:1383-1392. 2005. (Pubitemid 40837325)
19. Kothlow, S., R. Hauslaigner, B. Kaspers, and C. Grund. Evaluation of Newcastle disease virus immunoassays for waterfowl using a monoclonal antibody specific for the duck immunoglobulin light chain. Avian Pathol. 37:323-328. 2008. (Pubitemid 351882795)
20. Lambrecht, B., M. Gonze, G. Meulemans, and T. P. van den Berg. Assessment of the cell-mediated immune response in chickens by detection of chicken interferon-gamma in response to mitogen and recall Newcastle disease viral antigen stimulation. Avian Pathol. 33:343-350. 2004. (Pubitemid 38940897)
21. Lawson, S., L. Rothwell, B. Lambrecht, K. Howes, K. Venugopal, and P. Kaiser. Turkey and chicken interferon-gamma, which share high sequence identity, are biologically cross-reactive. Dev. Comp. Immunol. 25:69-82. 2001. (Pubitemid 30654940)
22. Mestecky, J., and P. L. Ogra. Mucosal immunoglobulins. In: Mucosal immunology. J. Mestecky, ed. Academic Press, San Diego. pp. 133-152. 1999.
23. Nayak, B., S. N. Rout, S. Kumar, M. S. Khalil, M. M. Fouda, L. E. Ahmed, K. C. Earhart, D. R. Perez, P. L. Collins, and S. K. Samal. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS One 4:e6509. 2009.
24. Pantin-Jackwood, M. J., D. L. Suarez, E. Spackman, and D. E. Swayne. Age at infection affects the pathogenicity of Asian highly pathogenic avian influenza H5N1 viruses in ducks. Virus Res. 130:151-161. 2007. (Pubitemid 350064319)
25. Park, M. S., J. Steel, A. Garcia-Sastre, D. Swayne, and P. Palese. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc. Natl. Acad. Sci. U. S. A. 103:8203-8208. 2006. (Pubitemid 43801076)
26. Peeters, B. P. H., O. S. de Leeuw, G. Koch, and A. L. J. Gielken. Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73:5001-5009. 1999. (Pubitemid 29246761)
27. Pfeiffer, J., D. L. Suarez, L. Sarmento, T. L. To, T. Nguyen, and M. J. Pantin-Jackwood. Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam. Avian Dis. 54:262-271. 2010.
28. Phuong, D. Q., N. T. Dung, P. H. Jorgensen, K. J. Handberg, N. T. Vinh, and J. P. Christensen. Susceptibility of Muscovy (Cairina moschata) and mallard ducks (Anas platyrhynchos) to experimental infections by different genotypes of H5N1 avian influenza viruses. Vet. Microbiol. 2010.
29. Prel, A., G. Le Gall-Recule, and V. Jestin. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against lowpathogenic avian influenza strains in ducks. Avian Pathol. 37:513-520. 2008.
30. Qi, X., X. Yang, A. Cheng, M. Wang, D. Zhu, R. Jia, Q. Luo, and X. Chen. Intestinal mucosal immune response against virulent duck enteritis virus infection in ducklings. Res. Vet. Sci. 87:218-225. 2009.
31. Rauw, F., Y. Gardin, V. Palya, S. Van Borm, M. Gonze, S. Lemaire, and T. van den Berg. Humoral, cell-mediated and mucosal immunity induced by oculo-nasal vaccination of one-day-old SPF and conventional layer chicks with two different live Newcastle disease vaccines. Vaccine 27:3631-3642. 2009.
32. Rauw, F., S. Anbari, T. van den Berg, and B. Lambrecht. Measurement of systemic and local respiratory cell-mediated immunity after influenza infection in chickens. Vet. Immunol. Immunopathol. 143:27-37. 2011.
33. Römer-Oberdörfer, A., E. Mundt, T. Mebatsion, U. J. Buchholz, and T. C. Mettenleiter. Generation of recombinant lentogenic Newcastle disease virus from cDNA. J. Gen. Virol. 80:2987-2995. 1999. (Pubitemid 29504672)
34. Saade, F., T. Buronfosse, P. Pradat, F. Abdul, and L. Cova. Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes. Vaccine 19:5159-5164. 2008.
35. Sarfati-Mizrahi, D., B. Lozano-Dubernard, E. Soto-Priante, F. Castro-Peralta, R. Flores-Castro, E. Loza-Rubio, and M. Gay-Gutierrez. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels. Avian Dis. 54:239-241. 2010.
36. Spackman, E., D. A. Senne, T. J. Myers, L. L. Bulaga, L. P. Garber, M. L. Perdue, K. Lohman, L. T. Daum, and D. L. Suarez. Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J. Clin. Microbiol. 40:3256-3260. 2002. (Pubitemid 34977437)
37. Steensels, M., S. Van Borm, B. Lambrecht, J. De Vriese, F. X. Le Gros, M. Bublot, and T. van den Berg. Efficacy of an inactivated and a fowlpox-vectored vaccine in Muscovy ducks against an Asian H5N1 highly pathogenic avian influenza viral challenge. Avian Dis. 51:325-331. 2007. (Pubitemid 46671302)
38. Steensels, M. Novel vaccination strategies to protect birds against Asian highly pathogenic H5N1 influenza viruses. Department Biosystems, Katholieke Universiteit Leuven, Leuven, Belgium. p. 150. 2009.
39. Steensels, M., M. Bublot, S. Van Borm, J. De Vriese, B. Lambrecht, A. Richard-Mazet, S. Chanavat-Bizzini, M. Duboeuf, F.-X. Le Gros, and T. van den Berg. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 27:646-654. 2009.
40. Steensels, M., M. Bublot, S. Van Borm, J. De Vriese, B. Lambrecht, A. Richard-Mazet, S. Chanavat-Bizzini, M. Duboeuf, F. X. Le Gros, and T. van den Berg. Prime-boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI. Vaccine 27:646-654. 2009.
41. Sturm-Ramirez, K. M., T. Ellis, B. Bousfield, L. Bissett, K. Dyrting, J. E. Rehg, L. Poon, Y. Guan, M. Peiris, and R. G. Webster. Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J. Virol. 78:4892-4901. 2004. (Pubitemid 38501109)
42. Sturm-Ramirez, K. M., D. J. Hulse-Post, E. A. Govorkova, J. Humberd, P. Seiler, P. Puthavathana, C. Buranathai, T. D. Nguyen, A. Chaisingh, H. T. Long, T. S. Naipospos, H. Chen, T.M. Ellis, Y. Guan, J. S. Peiris, and R. G. Webster. Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J. Virol. 79:11269-11279. 2005. (Pubitemid 41170669)
43. Swayne, D. E., D. A. Senne, and C. W. Beard. Avian influenza. In: A laboratory manual for the isolation and identification of avian pathogens, 4th ed. J. R. Glisson, D. E. Swayne, M. W. Jackwood, J. E. Pearson, and W. M. Reed, eds. American Association of Avian Pathologists, Kennet Square, PA. pp. 150-155. 1998.
44. Swayne, D. E., D. L. Suarez, S. Schultz-Cherry, T. M. Tumpey, D. J. King, T. Nakaya, P. Palese, and A. Garcia-Sastre. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis. 47:1047-1050. 2003. (Pubitemid 37143880)
45. Swayne, D. E., and D. R. Kapczynski. Vaccines, vaccination, and immunology for avian influenza viruses in poultry. In: Avian influenza. D. Swayne, ed. Blackwell Publishing, Ames, IA. pp. 407-451. 2008.
46. Thermet, A., T. Buronfosse, B. Werle-Lapostolle, M. Chevallier, P. Pradat, C. Trepo, F. Zoulim, and L. Cova. DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection. J. Gen. Virol. 89:1192-1201. 2008.
47. Tian,G., S. Zhang, Y. Li, Z. Bu, P. Liu, J. Zhou, C. Li, J. Shi, K. Yu, and H. Chen. Protective efficacy in chickens, geese and ducks of an H5N1-inactivated vaccine developed by reverse genetics. Virology 341:153-162. 2005. (Pubitemid 41356582)
48. Tian, G.,X.Zeng, Y. Li, J. Shi, andH. Chen.Protective efficacy of theH5 inactivated vaccine against different highly pathogenic H5N1 avian influenza viruses isolated in China and Vietnam. Avian Dis. 54:287-289. 2010.
49. Tong, S., Y. Li, P. Rivailler, C. Conrardy, D. A. Castillo, L. M. Chen, S. Recuenco, J. A. Ellison, C. T. Davis, I. A. York, A. S. Turmelle, D. Moran, S. Rogers, M. Shi, Y. Tao, M. R. Weil, K. Tang, L. A. Rowe, S. Sammons, X. Xu, M. Frace, K. A. Lindblade, N. J. Cox, L. J. Anderson, C. E. Rupprecht, and R. O. Donis. A distinct lineage of influenza A virus from bats. Proc. Natl. Acad. Sci. U. S. A. 109:4269-4274. 2012.
50. Van Borm, S., M. Steensels, H. L. Ferreira, M. Boschmans, J. De Vriese, B. Lambrecht, and T. van den Berg. A universal avian endogenous real-time reverse transcriptase-polymerase chain reaction control and its application to avian influenza diagnosis and quantification. Avian Dis. 51:213-220. 2007. (Pubitemid 46671282)
51. van den Berg, T., B. Lambrecht, S. Marche, M. Steensels, S. Van Borm, and M. Bublot. Influenza vaccines and vaccination strategies in birds. Comp. Immunol. Microbiol. Infect. Dis. 31:121-165. 2008. (Pubitemid 351315113)
52. van der Goot, J. A., M. van Boven, M. C. de Jong, and G. Koch. Effect of vaccination on transmission of HPAI H5N1: the effect of a single vaccination dose on transmission of highly pathogenic avian influenza H5N1 in Peking ducks. Avian Dis. 51:323-324. 2007. (Pubitemid 46671301)
53. Veits, J., A. Romer-Oberdorfer, D. Helferich, M. Durban, Y. Suezer, G. Sutter, and T. C. Mettenleiter. Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions. Vaccine 26:1688-1696. 2008.
54. Volmer, C., S. Soubies, B. Grenier, J. L. Guérin, and R. Volmer. Immune response in the duck intestine following infection with low pathogenic avian influenza viruses or stimulation with a TLR7 agonist administered orally. J. Gen. Virol. 92(Pt 3):534-543. 2011.
55. Wright, P. F., G. Neumann, and Y. Kawaoka. Orthomyxoviruses. In: Fiels virology, 5th ed. D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus, eds. Lippincott Williams & Wilkins, Philadelphia. pp. 1692-1740. 2007.
56. Yang, X., X. Qi, A. Cheng, M. Wang, D. Zhu, R. Jia, and X. Chen. Intestinal mucosal immune response in ducklings following oral immunisation with an attenuated duck enteritis virus vaccine. Vet. J. 185:199-203. 2010.